|  Help  |  About  |  Contact Us

Publication : Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.

First Author  Zhou X Year  2021
Journal  Cell Death Dis Volume  12
Issue  6 Pages  521
PubMed ID  34021120 Mgi Jnum  J:315780
Mgi Id  MGI:6812714 Doi  10.1038/s41419-021-03758-w
Citation  Zhou X, et al. (2021) Wnt/Beta-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells. Cell Death Dis 12(6):521
abstractText  The developmental origins of mesenchymal progenitor cells (MPCs) and molecular machineries regulating their fate and differentiation are far from defined owing to their complexity. Osteoblasts and adipocytes are descended from common MPCs. Their fates are collectively determined by an orchestra of pathways in response to physiological and external cues. The canonical Wnt pathway signals MPCs to commit to osteogenic differentiation at the expense of adipogenic fate. In contrast to Beta-catenin, p53's anti-osteogenic function is much less understood. Both activities are thought to be achieved through targeting Runx2 and/or Osterix (Osx, Sp7) transcription. Precisely, how Osx activity is dictated by Beta-catenin or p53 is not clarified and represents a knowledge gap that, until now, has largely been taken for granted. Using conditional lineage-tracing mice, we demonstrated that chondrocytes gave rise to a sizable fraction of MPCs, which served as progenitors of chondrocyte-derived osteoblasts (Chon-ob). Wnt/Beta-catenin activity was only required at the stage of chondrocyte-derived mesenchymal progenitor (C-MPC) to Chon-ob differentiation. Beta-catenin(-) C-MPCs lost osteogenic ability and favored adipogenesis. Mechanistically, we discovered that p53 activity was elevated in Beta-catenin(-) MPCs including Beta-catenin(-) C-MPCs and deleting p53 from the Beta-catenin(-) MPCs fully restored osteogenesis. While high levels of p53 were present in the nuclei of Beta-catenin(-) MPCs, Osx was confined to the cytoplasm, implying a mechanism that did not involve direct p53-Osx interaction. Furthermore, we found that p53's anti-osteogenic activity was dependent on its DNA-binding ability. Our findings identify chondrocytes as an additional source for MPCs and indicate that Wnt/Beta-catenin discretely regulates chondrocyte to C-MPC and the subsequent C-MPC to osteoblast developments. Most of all we unveil a previously unrecognized functional link between Beta-catenin and p53, placing p53's negative role in the context of Wnt/Beta-catenin signaling-induced MPC osteogenic differentiation.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

20 Bio Entities

Trail: Publication

0 Expression